glutamic acid and Autoimmune Demyelinating Diseases, Central Nervous System

glutamic acid has been researched along with Autoimmune Demyelinating Diseases, Central Nervous System in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberdi, E; Domercq, M; Matute, C; Pérez-Cerdá, F; Pérez-Samartín, A; Sánchez-Gómez, MV; Torre, I1

Other Studies

1 other study(ies) available for glutamic acid and Autoimmune Demyelinating Diseases, Central Nervous System

ArticleYear
Activation of kainate receptors sensitizes oligodendrocytes to complement attack.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Mar-22, Volume: 26, Issue:12

    Topics: Animals; Animals, Newborn; Antioxidants; Calcium; Cell Death; Cell Membrane; Cells, Cultured; Complement System Proteins; Demyelinating Autoimmune Diseases, CNS; Dose-Response Relationship, Drug; Glutamic Acid; Male; Nerve Fibers, Myelinated; Neurotoxins; Oligodendroglia; Optic Nerve; Oxidative Stress; Patch-Clamp Techniques; Polynucleotide Adenylyltransferase; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid

2006